Similar articles for PMID: 27405041

Year	Number of Results
1987	2
1990	1
1993	1
1995	1
1996	1
1997	1
1998	1
1999	3
2000	2
2001	3
2003	3
2004	1
2005	4
2006	4
2007	5
2008	5
2010	3
2011	9
2012	15
2013	8
2014	10
2015	11
2016	15
2017	7
2018	6
2019	3
2020	5
2021	7
2022	5
2023	2
2024	0

1

Brain-Only Metastases Seen on FDG PET as First Relapse of Papillary Thyroid Carcinoma Two Years Post-Thyroidectomy.

Naddaf SY, Syed GM, Hadb A, Al-Thaqfi S. Naddaf SY, et al. Clin Nucl Med. 2016 Sep;41(9):693-4. doi: 10.1097/RLU.0000000000001305. Clin Nucl Med. 2016. PMID: 27405041

2

Effect of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography-guided management of suspected recurrent papillary thyroid carcinoma: long-term follow-up with tumour marker responses.

Dennis K, Hay JH, Wilson DC. Dennis K, et al. Clin Oncol (R Coll Radiol). 2012 Dec;24(10):e168-72. doi: 10.1016/j.clon.2012.08.002. Epub 2012 Sep 1. Clin Oncol (R Coll Radiol). 2012. PMID: 22944464

3

PSMA Expression in Papillary Thyroid Carcinoma: Opening a New Horizon in Management of Thyroid Cancer?

Taywade SK, Damle NA, Bal C. Taywade SK, et al. Clin Nucl Med. 2016 May;41(5):e263-5. doi: 10.1097/RLU.0000000000001148. Clin Nucl Med. 2016. PMID: 26914556

4

FDG PET of recurrent or metastatic 131I-negative papillary thyroid carcinoma.

Alnafisi NS, Driedger AA, Coates G, Moote DJ, Raphael SJ. Alnafisi NS, et al. J Nucl Med. 2000 Jun;41(6):1010-5. J Nucl Med. 2000. PMID: 10855626 Free article.

5

Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.

Kang JH, Jung DW, Pak KJ, Kim IJ, Kim HJ, Cho JK, Shin SC, Wang SG, Lee BJ. Kang JH, et al. Head Neck. 2018 Jan;40(1):94-102. doi: 10.1002/hed.24967. Epub 2017 Nov 11. Head Neck. 2018. PMID: 29130586

6

Impact of FDG-PET computed tomography for surgery of recurrent or persistent differentiated thyroid carcinoma.

Weber T, Ohlhauser D, Hillenbrand A, Henne-Bruns D, Reske SN, Luster M. Weber T, et al. Horm Metab Res. 2012 Nov;44(12):904-8. doi: 10.1055/s-0032-1316351. Epub 2012 Jul 12. Horm Metab Res. 2012. PMID: 22791600

7

18F-fluorodeoxyglucose positron emission tomography-computed tomography for suspected recurrent papillary thyroid cancer: early experience at Sunnybrook Health Sciences Centre.

Dahele M, Ung YC, Ehrlich L, Silverberg J, Balogh J, Wong CS. Dahele M, et al. J Otolaryngol Head Neck Surg. 2008 Oct;37(5):712-7. J Otolaryngol Head Neck Surg. 2008. PMID: 19128681

8

Axillary lymph node metastasis of papillary thyroid carcinoma detected by FDG PET/CT in a thyroglobulin-positive patient with negative whole-body 131I scan.

Elboga U, Kalender E, Yilmaz M, Celen YZ, Aktolun C. Elboga U, et al. Clin Nucl Med. 2012 Nov;37(11):1120-2. doi: 10.1097/RLU.0b013e318266cce9. Clin Nucl Med. 2012. PMID: 22996245

9

Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.

Nascimento C, Borget I, Al Ghuzlan A, Deandreis D, Hartl D, Lumbroso J, Berdelou A, Lepoutre-Lussey C, Mirghani H, Baudin E, Schlumberger M, Leboulleux S. Nascimento C, et al. Thyroid. 2015 Apr;25(4):437-44. doi: 10.1089/thy.2014.0320. Epub 2015 Mar 16. Thyroid. 2015. PMID: 25633259

10

Initial experience in use of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in thyroid carcinoma patients with elevated serum thyroglobulin but negative iodine-131 whole body scans.

Ong SC, Ng DC, Sundram FX. Ong SC, et al. Singapore Med J. 2005 Jun;46(6):297-301. Singapore Med J. 2005. PMID: 15902358 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

131 results

Results by year